Literature DB >> 11756371

Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome.

Arieh Raziel1, Shevach Friedler, Morey Schachter, Deborah Strassburger, Eitan Mordechai, Raphael Ron-El.   

Abstract

BACKGROUND: Since severe ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of assisted reproduction, the focus of attention in such cases is placed firmly upon the health of the patient, with the endeavour to achieve a pregnancy being considered of secondary importance. The aim of this study was to focus on the pregnancy rate and pregnancy outcome in IVF patients hospitalized for severe or critical OHSS, in one centre, during a period of 6 years.
METHODS: We compared the characteristics of patients with severe OHSS: those who conceived with the ones who did not conceive, and among pregnant IVF patients, those with ongoing pregnancies with those that miscarried.
RESULTS: Pregnancy was achieved in 60 of 104 (58%) patients with severe OHSS. Pregnancy continued until delivery in 37 of these 60 patients (62%), whereas the remaining 23 (38%) aborted. The pregnancy and abortion rates in patients with severe OHSS were significantly higher than those of IVF patients without OHSS, during the same time period [23% (1138/4922) and 15% (169/1138) respectively, P < 0.001]. The mean duration of hospitalization for OHSS was significantly shorter in those who delivered compared with those who aborted (5.9 +/- 3.2 versus 10.5 +/- 9.6 days, P < 0.01) and in the non-pregnant patients compared with the pregnant patients (5.2 +/- 3.2 versus 7.6 +/- 6.6 days, P < 0.02).
CONCLUSIONS: The clinical pregnancy rate of IVF patients with severe OHSS was significantly higher than that of patients without the syndrome. A longer stay in hospital-reflecting a more severe form of OHSS-was correlated with a higher frequency of abortions. OHSS, necessitating hospitalization, is a detrimental clinical situation not only for the mother but also for the developing pregnancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756371     DOI: 10.1093/humrep/17.1.107

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes.

Authors:  Katherine L Palmerola; Briana J Rudick; Rogerio A Lobo
Journal:  J Assist Reprod Genet       Date:  2018-04-27       Impact factor: 3.412

3.  In vitro fertilization outcome in severe ovarian hyperstimulation syndrome: An age-matched contemporaneous control study.

Authors:  Soon Pheng Ng; Zainul Rashid Mr; Jothi Kumar; Soon Chye Ng
Journal:  Reprod Med Biol       Date:  2005-07-28

4.  Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study.

Authors:  Kazem Nouri; Peter Haslinger; Ladislaus Szabo; Michael Sator; Martin Schreiber; Christian Schneeberger; Detlef Pietrowski
Journal:  J Ovarian Res       Date:  2014-05-13       Impact factor: 4.234

5.  Effect of pigtail catheter application on obstetric outcomes in in vitro fertilization/intracytoplasmic sperm injection pregnancies following hyperstimulation syndrome.

Authors:  Pınar Çağlar Aytaç; Hakan Kalaycı; Selçuk Yetkinel; Didem Alkaş; Seda Yüksel Şimşek; Bülent Haydardedeoğlu; Esra Bulgan Kılıçdağ
Journal:  Turk J Obstet Gynecol       Date:  2017-06-15

6.  Co action of CFTR and AQP1 increases permeability of peritoneal epithelial cells on estrogen-induced ovarian hyper stimulation syndrome.

Authors:  Pei-Yin Jin; Yong-Chao Lu; Ling Li; Qin-Fu Han
Journal:  BMC Cell Biol       Date:  2012-08-28       Impact factor: 4.241

7.  Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.

Authors:  Xuan Jiang; Cheng-Yan Deng; Zheng-Yi Sun; Wei-Lin Chen; Han-Bi Wang; Yuan-Zheng Zhou; Li Jin
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

8.  Pharmacokinetics and Bioavailability of the GnRH Analogs in the Form of Solution and Zn2+-Suspension After Single Subcutaneous Injection in Female Rats.

Authors:  Aleksandra Suszka-Świtek; Florian Ryszka; Barbara Dolińska; Renata Dec; Alojzy Danch; Łukasz Filipczyk; Ryszard Wiaderkiewicz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

9.  Blastocyst-stage embryos provide better frozen-thawed embryo transfer outcomes for young patients with previous fresh embryo transfer failure.

Authors:  Lanlan Fang; Jingyan He; Yang Yan; Qiongqiong Jia; Yiping Yu; Ruizhe Zhang; Jung-Chien Cheng; Ying-Pu Sun
Journal:  Aging (Albany NY)       Date:  2020-04-15       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.